How brain cells called astrocytes change after spinal cord injuries and affect healing
Astrocyte dynamics in spinal cord injury and their impact on regeneration
This study is looking at how certain brain cells called astrocytes help or hinder healing after spinal cord injuries, with the hope of finding new ways to improve recovery for people who have these injuries.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10901468 on NIH RePORTER |
What this research studies
This research investigates the role of astrocytes, a type of brain cell, in the healing process following spinal cord injuries. It aims to understand how these cells change their behavior after an injury and how these changes impact the body's ability to regenerate nerve tissue. By examining the interactions between astrocytes and neurons, the research seeks to uncover the mechanisms that either promote or hinder recovery. This could lead to new insights into improving healing and recovery for patients with spinal cord injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced spinal cord injuries and are seeking innovative therapeutic options.
Not a fit: Patients with spinal cord injuries that are too old or have other complicating health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments that enhance recovery from spinal cord injuries, potentially restoring function and quality of life for patients.
How similar studies have performed: Previous research has shown promise in understanding astrocyte behavior in other contexts, but this specific approach to spinal cord injury is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Hulegaard, Alexandria Lassetter — University of Pennsylvania
- Study coordinator: Hulegaard, Alexandria Lassetter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.